Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 182
Articles

Lipid Treatment for Uninsured Populations with Severe Hypercholesterolemia

The characterization and treatment of severe hypercholesterolemia among patients within large health systems have been studied extensively.1-6 However, little is known about the burden of…

Read More |
Articles

Pharmacotherapy in Obesity: Not Just for Three Months

Overweight and obesity rates continue to climb worldwide, contributing to significant morbidity and mortality, despite several effective pharmacotherapy treatments that are grossly underutilized. Obesity is…

Read More |
Articles

When Is It Reasonable to Consider Withholding Lipid Lowering Therapy?

Lipid lowering therapy is a cornerstone of cardiovascular risk reduction. However, withholding or stopping lipid lowering therapy may be worth consideration in some individuals. These…

Read More |
Articles

Improving Lipid Management for the Acute Coronary Syndrome Patient

Introduction It’s been over 20 years since the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial1 ushered in the initiation of aggressive LDL-C lowering…

Read More |
Articles

How We Do It: Lipid Specialists Pushing Boundaries to Improve Patient Care Across a Variety of Practice Settings

The NLA now includes > 2,000 members with representation from physicians, NP/PAs, clinical pharmacists, dietitians, and other healthcare professionals. In this Clinical Feature, we highlight…

Read More |
Articles

Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

Statin-associated muscle symptoms (SAMS) are the most common form of statin intolerance and are associated with increased risk of cardiovascular events that manifest from statin…

Read More |
Articles

Cardiometabolic Syndrome: A Package Deal

Cardiometabolic syndrome, also known as “metabolic syndrome,” refers to a constellation of metabolic abnormalities and cardiovascular risk factors clustered in a given patient. The definitions…

Read More |
Articles

Inflammation in Obesity and Cardiovascular Disease

Obesity is a chronic, relapsing, heterogenous disease characterized by impaired energy regulation and inflammation that leads to cardiometabolic, biomechanical, and psychosocial health consequences. The prevalence…

Read More |